7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors

NCT00012194 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: 7-hydroxystaurosporine
DRUG: cisplatin
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)